Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorders, Lymphoproliferative”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00089453
What this trial is testing

Study of KIR-Ligand Mismatched Haplo-Identical Natural Killer Cells Transfused Before Autologous Stem Cell Transplant

Who this might be right for
Multiple Myeloma
University of Arkansas 10
Testing effectiveness (Phase 2)Ended earlyNCT00208975
What this trial is testing

Phase II Study of Fludarabine and Mitoxantrone, Followed by GM-CSF(Granulocyte-macrophage Colony-stimulating Factor) and Rituximab

Who this might be right for
Lymphoma
Emory University 15
Very early researchUnknownNCT05739227
What this trial is testing

Safety and Efficacy of Allogenic CD19-CAR-NK Cells in Treatmenting r/r B-cell Hematologic Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaB-cell LymphomaChronic Lymphocytic Leukemia
Xuzhou Medical University 12
Large-scale testing (Phase 3)Looking for participantsNCT06561854
What this trial is testing

Study Comparing Therapy for Advanced Relapsed/Refractory Multiple Myeloma With and Without Dexamethasone

Who this might be right for
Multiple MyelomaRelapse Multiple Myeloma
Assistance Publique - Hôpitaux de Paris 318
Testing effectiveness (Phase 2)Active Not RecruitingNCT05190705
What this trial is testing

Loncastuximab Tesirine in WM

Who this might be right for
Waldenstrom Macroglobulinemia
Shayna Sarosiek, MD 21
Not applicableStudy completedNCT03463694
What this trial is testing

Edinburgh and Lothian Virus Intervention Study in Kids

Who this might be right for
Upper Respiratory Tract InfectionsVirusVirus Shedding+1 more
University of Edinburgh 407
Early research (Phase 1)UnknownNCT05412329
What this trial is testing

Study of Dual Targeted CD19/BCMA FASTCART GC012F in Relapsed/ Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Shanghai Changzheng Hospital 9
Testing effectiveness (Phase 2)Study completedNCT04436029
What this trial is testing

Descartes-11 Consolidation Treatment in Patients With High-Risk Multiple Myeloma Who Have Residual Disease After Induction Therapy

Who this might be right for
Multiple Myeloma
Cartesian Therapeutics 5
Testing effectiveness (Phase 2)Ended earlyNCT03401853
What this trial is testing

Pembrolizumab With Rituximab or Obinutuzumab in Treating Patients With Relapsed or Refractory Follicular Lymphoma or Diffuse Large B Cell Lymphoma

Who this might be right for
Recurrent Diffuse Large B-Cell LymphomaRecurrent Follicular LymphomaRefractory Diffuse Large B-Cell Lymphoma+1 more
University of Washington 18
Post-approval studies (Phase 4)Looking for participantsNCT06831370
What this trial is testing

Brentuximab Vedotin With Doxorubicin, Vinblastine and Dacarbazine in Adults With Hodgkin Lymphoma in India

Who this might be right for
Hodgkin Lymphoma
Takeda 124
Early research (Phase 1)Study completedNCT03489369
What this trial is testing

Sym022 (Anti-LAG-3) in Patients With Advanced Solid Tumor Malignancies or Lymphomas

Who this might be right for
Metastatic CancerSolid TumorLymphoma
Symphogen A/S 15
Testing effectiveness (Phase 2)UnknownNCT00081783
What this trial is testing

Xcellerated T CellsTM for Non-Hodgkin's Lymphoma (NHL) Patients

Who this might be right for
Non-Hodgkin's Lymphoma
Xcyte Therapies 40
Not applicableStudy completedNCT04531956
What this trial is testing

Implementation of a Diagnostic Decision-aid for People With Memory Complaints and Their General Practitioners

Who this might be right for
DementiaDementia AlzheimersDementia, Mild
Maastricht University 40
Not applicableLooking for participantsNCT06908629
What this trial is testing

Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors

Who this might be right for
CancerCancer SurvivorsGastrointestinal Cancers+2 more
Barbara Ann Karmanos Cancer Institute 120
Not applicableStudy completedNCT01697839
What this trial is testing

Serum Vitamin D Levels and Peripheral Neuropathy Among Multiple Myeloma Patients

Who this might be right for
Multiple MyelomaPeripheral Neuropathy
Oncotherapeutics 110
Early research (Phase 1)UnknownNCT05150405
What this trial is testing

A Phase Ia Clinical Study of QLF31907 Injection in Patients With Advanced Malignant Tumors

Who this might be right for
Solid TumorLymphoma, Non-Hodgkin
Qilu Pharmaceutical Co., Ltd. 54
Not applicableNo Longer AvailableNCT05215405
What this trial is testing

Expanded Access Program of Venetoclax and Navitoclax for Pediatric Patients with Relapsed or Refractory ALL or LL

Who this might be right for
Relapsed Childhood ALLRelapsed Childhood Lymphoblastic Lymphoma
Kathleen Ludwig
Early research (Phase 1)Active Not RecruitingNCT02992522
What this trial is testing

Obinutuzumab, Venetoclax, and Lenalidomide in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
B-Cell Lymphoma, UnspecifiedGrade 1 Follicular LymphomaGrade 2 Follicular Lymphoma+10 more
Beth Christian 22
Early research (Phase 1)UnknownNCT03618602
What this trial is testing

Safety, Pharmacokinetics and Efficacy Study of Bisthianostat in Refractory or Recurrent Multiple Myeloma Patients

Who this might be right for
Refractory Multiple MyelomaRecurrent Multiple Myeloma
Shanghai Theorion Pharmaceutical Co Ltd. 30
Large-scale testing (Phase 3)Study completedNCT00022737
What this trial is testing

Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic Leukemia

Who this might be right for
Childhood Acute Lymphoblastic Leukemia in RemissionRecurrent Childhood Acute Lymphoblastic Leukemia
National Cancer Institute (NCI) 220
Next Page